Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;32(7):e70257.
doi: 10.1111/ene.70257.

Interpreting Addenbrooke's Cognitive Examination-III Scores in Dementia: Performance Distributions and Clinically Meaningful Change

Affiliations

Interpreting Addenbrooke's Cognitive Examination-III Scores in Dementia: Performance Distributions and Clinically Meaningful Change

James Carrick et al. Eur J Neurol. 2025 Jul.

Abstract

Background: The Addenbrooke's Cognitive Examination-III (ACE-III) is a common cognitive screening measure. We provide performance deciles, descriptive performance bands and indices of reliable change between repeat assessments using the ACE-III in a large cohort of dementia participants and healthy controls.

Methods: Baseline data from 727 participants diagnosed with a dementia syndrome and 157 healthy controls were used to calculate performance deciles and descriptive bands. A subset of 393 participants diagnosed with a dementia syndrome completed two annual assessments. These data were used to calculate 95% confidence intervals of characteristic yearly change in each dementia syndrome. Data from a subset of 74 healthy participants who completed two assessments were used to calculate reliable change indices.

Results: Baseline performance was grouped into five descriptive performance bands across the entire spectrum of scores: Very Mild, Mild, Moderate, Severe and Very Severe. Deciles and performance bands are provided for all dementia participants combined, for each syndrome where n > 50, and for healthy controls, stratified by group, sex and years of education. A decline of -7 to -9 points yearly was characteristic for the dementia population, and this varied between syndromes. Reliable change calculations indicate that a 5-point decline from within the 'normal' range (88-100) is the minimum clinically important decline on the ACE-III.

Conclusions: This study presents a suite of reference data on the ACE-III in a range of dementia syndromes, providing important insight and support to clinicians who work with people living with cognitive impairments.

Keywords: Alzheimer's disease; cognitive screening; frontotemporal dementia; neurodegeneration; primary progressive aphasia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
ACE‐III first visit (T1) performance distribution for all dementia syndromes (combined). Derived T1 performance bands are overlaid. The X‐axis represents ACE‐III total score, and the Y‐axis represents the proportion of the sample that obtained that score. Demographic data for these participants is described in Table 1 (‘dementia [combined]’).

References

    1. Matias‐Guiu J. A., Cortés‐Martínez A., Valles‐Salgado M., et al., “Addenbrooke's Cognitive Examination III: Diagnostic Utility for Mild Cognitive Impairment and Dementia and Correlation With Standardized Neuropsychological Tests,” International Psychogeriatrics 29, no. 1 (2017): 105–113, 10.1017/S1041610216001496. - DOI - PubMed
    1. Giebel C. M. and Challis D., “Sensitivity of the Mini‐Mental State Examination, Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination III to Everyday Activity Impairments in Dementia: An Exploratory Study,” International Journal of Geriatric Psychiatry 32, no. 10 (2017): 1085–1093, 10.1002/gps.4570. - DOI - PubMed
    1. Hsieh S., Schubert S., Hoon C., Mioshi E., and Hodges J. R., “Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's Disease,” Dementia and Geriatric Cognitive Disorders 36, no. 3–4 (2013): 242–250, 10.1159/000351671. - DOI - PubMed
    1. Elamin M., Holloway G., Bak T. H., and Pal S., “The Utility of the Addenbrooke's Cognitive Examination Version Three in Early‐Onset Dementia,” Dementia and Geriatric Cognitive Disorders 41, no. 1–2 (2016): 9–15. - PubMed
    1. Foxe D., Hu A., Cheung S. C., et al., “Utility of the Addenbrooke's Cognitive Examination III Online Calculator to Differentiate the Primary Progressive Aphasia Variants,” Brain Communications 4, no. 4 (2022): fcac161, 10.1093/braincomms/fcac161. - DOI - PMC - PubMed